Psoriasis Treatment Cure
A new type of medication being studied and used for the treatment of psoriasis and psoriatic arthritis is called a biologic agent because of the way they are synthesized and the fact that they are proteins. The significant advances in understanding the causes of psoriasis and psoriatic arthritis have resulted in the development of this new class of medications. The biologic drugs target the abnormality in the immune system to modify the biology of the person with psoriasis or psoriatic arthritis back to normal.
As discussed, tumor necrosis factor-alpha (TNF-alpha) is one of many inflammatory messengers that can cause the tender; swollen joints of psoriatic arthritis and the red, scaly, raised areas of skin in psoriasis. TNF-alpha is increased in the skin and joints of patients with psoriasis and psoriatic arthritis. When TNF-alpha is increased, it causes a number of changes in the blood vessels, skin, and joints, which can result in inflammation in the skin and joints. Reducing the activated T-cells that cause the release of TNF-alpha or blocking this inflammatory messenger can reduce inflammation (redness and swelling) of the joints and improve the skin lesions of psoriasis.
